India’s tally of coronavirus infections stood at 7.37 million on Friday, having risen by 63,371 in the last 24 hours, Health Ministry data showed.
Deaths from COVID-19 infections rose by 895 to 112,161, the Ministry said.
India crossed the 7-million mark on Sunday, adding a million cases in just 13 days. It has the world’s second-highest tally after the United States, where the figure is nearing 8 million.
Meanwhile, a Chinese city is offering Sinovac Biotech’s experimental COVID-19 vaccine to essential workers and other high-risk groups, as part of a national programme, for about $60.
The eastern city of Jiaxin’s center for disease control and prevention (CDC) said in a statement on WeChat that two doses of the vaccine candidate, called CoronaVac, will cost 200 yuan ($29.75) per dose and that vaccinations for key groups, including medical professionals, have begun.
Chinese authorities have to date not released pricing details for potential COVID-19 vaccines. Hundreds of thousands of people have been given experimental vaccines in late-stage trials as part of an emergency inoculation programme launched in July.
It was not clear if Jiaxin city’s pricing includes subsidies. The city’s CDC declined to comment.